Yoichiro Otaki Selected Research

Yoichiro Otaki Research Topics

Disease

15	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 01/2011
14	Heart Failure 06/2023 - 01/2013
8	Peripheral Arterial Disease 01/2020 - 01/2015
6	Myocardial Infarction 10/2022 - 01/2013
3	Atrial Fibrillation 10/2023 - 10/2014
3	Coronary Artery Disease (Coronary Atherosclerosis) 06/2023 - 04/2014
3	Chronic Limb-Threatening Ischemia 08/2022 - 12/2015
3	Coronary Vasospasm (Coronary Artery Vasospasm) 11/2021 - 01/2011
3	Anemia 01/2019 - 05/2014
3	Diabetes Mellitus 11/2018 - 01/2014
2	Chronic Obstructive Pulmonary Disease (COPD) 02/2024 - 01/2022
2	Stroke (Strokes) 10/2023 - 07/2019
2	Acute Coronary Syndrome 06/2023 - 12/2017
2	Inflammation (Inflammations) 11/2022 - 04/2014
2	Malnutrition (Nutritional Deficiencies) 11/2022 - 01/2018
2	Obesity 08/2022 - 01/2014
2	Pulmonary Emphysema 01/2022 - 01/2022
2	Heart Diseases (Heart Disease) 06/2021 - 02/2017
2	Coronary Stenosis (Coronary Artery Stenosis) 03/2021 - 01/2019
2	Cardiomegaly (Heart Hypertrophy) 12/2020 - 01/2020
2	Myocardial Ischemia (Ischemic Heart Diseases) 11/2018 - 01/2018
2	Atherosclerosis 01/2018 - 01/2016
2	Insulin Resistance 08/2016 - 04/2014
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2016 - 01/2014
2	Cardiotoxicity 01/2016 - 05/2015
1	Asthma (Bronchial Asthma) 02/2024
1	Emphysema 02/2024
1	Respiratory Tract Diseases (Respiratory Tract Disease) 02/2024
1	Hypokalemia 11/2023
1	Hemorrhage 06/2023
1	Out-of-Hospital Cardiac Arrest 01/2022
1	Hyperhomocysteinemia 01/2022
1	Aneurysm (Aneurysms) 03/2021
1	Abdominal Aortic Aneurysm 03/2021
1	Hypertrophy 12/2020
1	Aortic Valve Insufficiency (Aortic Regurgitation) 01/2020
1	Iron Deficiencies 03/2019
1	Coronary Disease (Coronary Heart Disease) 12/2017
1	Stable Angina 12/2017
1	Pulmonary Embolism 11/2017
1	Cardiac Arrhythmias (Arrythmia) 11/2017

Drug/Important Bio-Agent (IBA)

5	Xanthine DehydrogenaseIBA 01/2023 - 02/2017
5	Proteins (Proteins, Gene)FDA Link 12/2020 - 11/2014
5	Brain Natriuretic Peptide (Natrecor)FDA Link 07/2019 - 05/2014
5	Fatty Acid Binding Protein 3IBA 02/2018 - 01/2014
4	CreatinineIBA 11/2023 - 01/2015
4	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2015
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 01/2016
3	SmokeIBA 02/2024 - 01/2022
3	CytokinesIBA 01/2024 - 01/2013
3	Proteasome Endopeptidase Complex (Proteasome)IBA 06/2021 - 01/2016
3	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 06/2021 - 01/2016
3	UbiquitinIBA 06/2021 - 01/2016
3	Fatty Acid-Binding ProteinsIBA 02/2018 - 12/2015
3	Cystatin CIBA 10/2016 - 01/2011
2	Growth Differentiation Factor 15IBA 06/2023 - 01/2023
2	omega-Chloroacetophenone (Mace)IBA 06/2023 - 01/2013
2	Troponin T (Troponin T1)IBA 07/2019 - 12/2015
2	pro-brain natriuretic peptide (1-76)IBA 07/2019 - 01/2019
2	CollagenIBA 02/2017 - 01/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 05/2015
2	ThioredoxinsIBA 01/2016 - 11/2014
2	Messenger RNA (mRNA)IBA 01/2016 - 05/2015
1	EnzymesIBA 02/2024
1	1-Acylglycerophosphocholine O-Acyltransferase (1 Acylglycerophosphocholine O Acyltransferase)IBA 02/2024
1	Platelet Activating FactorIBA 02/2024
1	RNA (Ribonucleic Acid)IBA 02/2024
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2024
1	PotassiumIBA 11/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2023
1	AlbuminsIBA 11/2022
1	GlobulinsIBA 11/2022
1	CC ChemokinesIBA 01/2022
1	Pancreatic Elastase (Elastase)IBA 01/2022
1	Chemokine CCL17IBA 01/2022
1	LigandsIBA 01/2022
1	Ligases (Synthetase)IBA 06/2021
1	CateninsIBA 12/2020
1	CalciumIBA 01/2020
1	locked nucleic acidIBA 01/2020
1	Atrial Natriuretic Factor (ANF)IBA 07/2019
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2019
1	Serum AlbuminIBA 11/2018
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2018
1	Cilostazol (Pletal)FDA LinkGeneric 01/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2017
1	LipidsIBA 12/2017
1	Eicosapentaenoic AcidIBA 12/2017
1	Collagen Type I (Type I Collagen)IBA 02/2017
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 02/2017

Therapy/Procedure

12	Therapeutics 08/2022 - 01/2015
5	Percutaneous Coronary Intervention 10/2022 - 01/2013
3	Patient Readmission 06/2023 - 07/2013
1	Catheter Ablation 10/2023
1	Activities of Daily Living (ADL) 10/2022
1	Intranasal Administration 01/2022
1	Perioperative Period 03/2021
1	Endovascular Aneurysm Repair 03/2021
1	Aftercare (After-Treatment) 01/2020
1	Secondary Prevention 12/2017